Current status of breast cancer prevention in China

Código QR

Current status of breast cancer prevention in China

Guardado en:

Detalles Bibliográficos
Autores principales:	Fei Wang, Zhi-Gang Yu
Formato:	article
Lenguaje:	EN
Publicado:	KeAi Communications Co., Ltd. 2015
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/8ceede38934f42eeab57b8cdf2c06908
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Intracranial artery stenosis: Current status of evaluation and treatment in China
por: Bin Cai, et al.
Publicado: (2017)

Current neoadjuvant treatment options for HER2 positive breast cancer
por: Abdel-Razeq H, et al.
Publicado: (2011)

Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer
por: Jaclyn Flanigan, et al.
Publicado: (2010)

China's Medium-to-Long Term Plan for the Prevention and Treatment of Chronic Diseases (2017â2025) under the Healthy China Initiative
por: Ling-Zhi Kong
Publicado: (2017)

The Current Status of Gene Therapy for the Treatment of Cancer
por: Belete TM
Publicado: (2021)

Factors Affecting Nodal Status in Breast Cancer
por: Diaa Aboelata, et al.
Publicado: (2020)

Porcine dermis implants in soft-tissue reconstruction: current status
por: Smart NJ, et al.
Publicado: (2014)

Screening for candidate genes related to breast cancer with cDNA microarray analysis
por: Yu-Juan Xiang, et al.
Publicado: (2015)

Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer
por: Chenxuan Yang, et al.
Publicado: (2021)

Prevention of Acute Postoperative Pain in Breast Cancer: A Comparison between Opioids versus Ketamine in the Intraoperatory Analgesia
por: Mirian López, et al.
Publicado: (2021)

A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment
por: Lee JJ, et al.
Publicado: (2017)

New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China
por: Da-Yi Hu
Publicado: (2017)

Current Status of Photodynamic Diagnosis for Gastric Tumors
por: Hiroki Kurumi, et al.
Publicado: (2021)

Nanomedicine applications in the treatment of breast cancer: current state of the art
por: Wu D, et al.
Publicado: (2017)

Current strategies for the prevention of breast cancer
por: Advani P, et al.
Publicado: (2014)

Progress in targeted therapy for breast cancer
por: Jie Ju, et al.
Publicado: (2018)

Management of breast cancer brain metastases: Focus on human epidermal growth factor receptor 2-positive breast cancer
por: Peng Yuan, et al.
Publicado: (2017)

The molecular profile of luminal B breast cancer
por: Creighton CJ
Publicado: (2012)

Eribulin mesylate in the treatment of metastatic breast cancer
por: Jain S, et al.
Publicado: (2012)

Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial
por: Si‐Yuan Zhu, et al.
Publicado: (2021)

Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
por: Jia Li, et al.
Publicado: (2009)

Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention
por: Shirode AB, et al.
Publicado: (2015)

HER2 breast cancer therapies: a review
por: Conleth G Murphy, et al.
Publicado: (2009)

Bevacizumab in the treatment of HER2-negative breast cancer
por: Vito Lorusso
Publicado: (2008)

Efficacy and feasibility of the immunomagnetic separation based diagnosis for detecting sentinel lymph node metastasis from breast cancer
por: Zhi XC, et al.
Publicado: (2015)

Current Challenges in Breast Implantation
por: Zuzanna Pelc, et al.
Publicado: (2021)

Granulomatous lobular mastitis
por: Fei Zhou, et al.
Publicado: (2016)

Sex-Specific Association Between Socioeconomic Status, Lifestyle, and the Risk of Frailty Among the Elderly in China
por: Huai-yu Wang, et al.
Publicado: (2021)

Cytotoxicity and apoptosis induced by nanobacteria in human breast cancer cells
por: Zhang MJ, et al.
Publicado: (2013)

Evaluation of glycophenotype in breast cancer by quantum dot-lectin histochemistry
por: Andrade CG, et al.
Publicado: (2013)

A meta-analysis of the prognosis in patients with breast cancer with ipsilateral supraclavicular lymph node metastasis versus patients with stage IIIb/c or IV breast cancer
por: Xu-Hong Liu, et al.
Publicado: (2015)

Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer
por: Sun S, et al.
Publicado: (2014)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner J, et al.
Publicado: (2015)

Photodynamic therapy of a 2-methoxyestradiol tumor-targeting drug delivery system mediated by Asn-Gly-Arg in breast cancer
por: Shi J, et al.
Publicado: (2013)

High drug-loading nanomedicines: progress, current status, and prospects
por: Shen SH, et al.
Publicado: (2017)

Cytotoxicity of various types of gold-mesoporous silica nanoparticles in human breast cancer cells
por: Liu G, et al.
Publicado: (2015)

Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies
por: Li B, et al.
Publicado: (2012)

Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications
por: Yallapu MM, et al.
Publicado: (2012)

Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer
por: Shannon Puhalla, et al.
Publicado: (2008)

Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy
por: Maji R, et al.
Publicado: (2014)